PT Sejahteraraya Anugrahjaya Tbk (SRAJ.JK)
IDR 2260.0
(-3.42%)
IDR 2260.0
(-3.42%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 437.22 Billion IDR | 75.89% |
| 2022 | 292.99 Billion IDR | -62.11% |
| 2021 | 455.64 Billion IDR | 327.84% |
| 2020 | 206.92 Billion IDR | 445.68% |
| 2019 | 28.08 Billion IDR | 63.93% |
| 2018 | 2.16 Billion IDR | 4.55% |
| 2017 | 6.18 Billion IDR | -8.55% |
| 2016 | 10.7 Billion IDR | 1.8% |
| 2015 | -22.09 Billion IDR | 8.99% |
| 2014 | -21.59 Billion IDR | -66.71% |
| 2013 | -40.16 Billion IDR | -184.18% |
| 2012 | 47.76 Billion IDR | 712.07% |
| 2011 | 47.62 Billion IDR | -29.28% |
| 2010 | 8.3 Billion IDR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 129.42 Billion IDR | -10.14% |
| 2024 Q1 | 70.85 Billion IDR | 1.93% |
| 2023 Q4 | 70.15 Billion IDR | 3.01% |
| 2023 Q2 | 31.89 Billion IDR | -35.15% |
| 2023 FY | - IDR | 75.89% |
| 2023 Q3 | 68.1 Billion IDR | 113.53% |
| 2023 Q1 | 49.18 Billion IDR | -11.27% |
| 2022 Q2 | -6.34 Billion IDR | -111.16% |
| 2022 Q4 | 55.43 Billion IDR | 185.6% |
| 2022 FY | - IDR | -62.11% |
| 2022 Q1 | 56.83 Billion IDR | 284.12% |
| 2022 Q3 | 19.41 Billion IDR | 406.01% |
| 2021 Q1 | 131.17 Billion IDR | 125.23% |
| 2021 FY | - IDR | 327.84% |
| 2021 Q3 | 104.51 Billion IDR | -15.33% |
| 2021 Q4 | -30.86 Billion IDR | -129.54% |
| 2021 Q2 | 123.44 Billion IDR | -5.9% |
| 2020 Q4 | 58.24 Billion IDR | 25.74% |
| 2020 Q2 | -27.68 Billion IDR | -544.61% |
| 2020 Q3 | 46.32 Billion IDR | 267.3% |
| 2020 Q1 | 6.22 Billion IDR | 111.61% |
| 2020 FY | - IDR | 445.68% |
| 2019 Q2 | -4.85 Billion IDR | -132.43% |
| 2019 FY | - IDR | 63.93% |
| 2019 Q3 | 21.14 Billion IDR | 535.39% |
| 2019 Q4 | -53.63 Billion IDR | -353.61% |
| 2019 Q1 | 14.97 Billion IDR | 143.63% |
| 2018 Q3 | -7.29 Billion IDR | 45.12% |
| 2018 Q2 | -13.29 Billion IDR | -35.02% |
| 2018 Q1 | -9.84 Billion IDR | 74.96% |
| 2018 FY | - IDR | 4.55% |
| 2018 Q4 | -34.32 Billion IDR | -370.53% |
| 2017 Q2 | -12.88 Billion IDR | -143.32% |
| 2017 Q1 | -5.29 Billion IDR | 72.0% |
| 2017 FY | - IDR | -8.55% |
| 2017 Q4 | -39.31 Billion IDR | -426.59% |
| 2017 Q3 | -7.46 Billion IDR | 42.04% |
| 2016 Q2 | -13.55 Billion IDR | -88.27% |
| 2016 FY | - IDR | 1.8% |
| 2016 Q4 | -18.9 Billion IDR | 8.2% |
| 2016 Q3 | -20.59 Billion IDR | -51.9% |
| 2016 Q1 | -7.2 Billion IDR | 49.62% |
| 2015 Q3 | -22.12 Billion IDR | -65.03% |
| 2015 Q2 | -13.4 Billion IDR | -20.56% |
| 2015 Q1 | -11.11 Billion IDR | 49.17% |
| 2015 FY | - IDR | 8.99% |
| 2015 Q4 | -14.29 Billion IDR | 35.39% |
| 2014 Q1 | -5.35 Billion IDR | 52.92% |
| 2014 FY | - IDR | -66.71% |
| 2014 Q4 | -21.87 Billion IDR | 34.71% |
| 2014 Q3 | -33.5 Billion IDR | -399.27% |
| 2014 Q2 | -6.71 Billion IDR | -25.38% |
| 2013 Q1 | 4.28 Billion IDR | -68.06% |
| 2013 Q2 | -1.77 Billion IDR | -141.39% |
| 2013 Q4 | -11.36 Billion IDR | 33.02% |
| 2013 Q3 | -16.97 Billion IDR | -857.2% |
| 2013 FY | - IDR | -184.18% |
| 2012 Q2 | 1.34 Billion IDR | -40.88% |
| 2012 Q1 | 2.28 Billion IDR | 101.71% |
| 2012 FY | - IDR | 712.07% |
| 2012 Q3 | 2.34 Billion IDR | 74.14% |
| 2012 Q4 | 13.41 Billion IDR | 471.26% |
| 2011 Q3 | 1.58 Billion IDR | 10.81% |
| 2011 Q2 | 1.43 Billion IDR | -16.7% |
| 2011 Q4 | 1.13 Billion IDR | -28.83% |
| 2011 FY | - IDR | -29.28% |
| 2011 Q1 | 1.72 Billion IDR | 0.0% |
| 2010 FY | - IDR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| PT Bundamedik Tbk | 223.9 Billion IDR | -95.272% |
| PT Metro Healthcare Indonesia Tbk | -7.68 Billion IDR | 5792.918% |
| PT Medikaloka Hermina Tbk | 1584.42 Billion IDR | 72.405% |
| PT Mitra Keluarga Karyasehat Tbk | 1555.38 Billion IDR | 71.889% |
| PT Murni Sadar Tbk | 155.6 Billion IDR | -180.982% |
| PT Famon Awal Bros Sedaya Tbk | 443.01 Billion IDR | 1.305% |
| PT Royal Prima Tbk | 52.4 Billion IDR | -734.279% |
| PT Kedoya Adyaraya Tbk | 61.12 Billion IDR | -615.338% |
| PT Sarana Meditama Metropolitan Tbk | 323.18 Billion IDR | -35.287% |
| PT Siloam International Hospitals Tbk | 2692.46 Billion IDR | 83.761% |